41
Topical & Transdermal Medications Christian Sinclair, MD Kansas City Hospice & Palliative Care October 8, 2008

Topical & Transdermal Medications in Palliative Medicine

Embed Size (px)

DESCRIPTION

DISCLAIMER: This slideset does not constitute medical advice. References are provided through out, please discuss with your own doctor or consult your own references before utilizing any information found in this slideset. Presented to the University of Kansas Palliative Medicine Fellowship lecture group.

Citation preview

Page 1: Topical & Transdermal Medications in Palliative Medicine

Topical & Transdermal Medications

Christian Sinclair, MD

Kansas City Hospice & Palliative Care

October 8, 2008

Page 2: Topical & Transdermal Medications in Palliative Medicine

Medication Routes

• Oral• Intravenous• Rectal• Intraosseous• Intrathecal• Inhaled• Optical• Topical

• Sublingual/Buccal• Subcutaneous• Intravesical• Intramuscular• Epidural• Insuffluation• Intravitreal• Transdermal

Page 3: Topical & Transdermal Medications in Palliative Medicine

Indications for Alternate Route

• Unwilling or unable to swallow meds• Cancers of the head, neck and GI tract• Compromise of the GI tract

– Mucositis– Bowel obstruction

• Intolerable side effects during administration• Treating localized pain• Avoiding systemic side effects• Neonatal/pediatric populations

Page 4: Topical & Transdermal Medications in Palliative Medicine

Topical versus Transdermal

• Topical– Treats at the site of medication placement

– Usually compounded, often non-branded

– Antibiotics for skin infection

– Steroid creams for rashes

• Transdermal– Treats via systemic delivery of the medication

– Usually branded and not compounded

– Hormone replacement, nicotine addiction, Duragesic

Page 5: Topical & Transdermal Medications in Palliative Medicine
Page 6: Topical & Transdermal Medications in Palliative Medicine

Variations

Page 7: Topical & Transdermal Medications in Palliative Medicine

Factors affecting absorption

• Flow increases with– Increased concentration– Increased surface area– Decreasing skin thickness– Lipophillic compounds– Low molecular weights

Page 8: Topical & Transdermal Medications in Palliative Medicine

Available Brand Medications

• Contraceptives/HRT

• Lidocaine

• Clonidine

• Nicotine

• EMLA

• Nitroglycerin

• Methylphenidate

• Estradiol

• Oxybutynin

• Estrogen

• Scopolamine

• Fentanyl

• Testosterone

Page 9: Topical & Transdermal Medications in Palliative Medicine

Compounding Vehicles

• PLO – Pluronic Lecithin Organogel

• Can hold guest molecules which are solubilized in the gel

• DMSO

• Other proprietary gels

Page 10: Topical & Transdermal Medications in Palliative Medicine

Other topical meds in Pubmed• Hormones-estriol and estradiol, DHEA, progesterone,

testosterone• NSAIDs-ketoprofen, diclofenac, piroxicam • SSRIs –fluoxetine, paroxetine • Antipsychotics-haloperidol, prochlorperazine • Levodopa• Morphine• Dexamethasone • Calcium channel blockers-diltiazem, nifedipine • Clonidine with gabapentin and ketamine• Lidocaine, tetracaine

Page 11: Topical & Transdermal Medications in Palliative Medicine

Evidence for Topical Meds

• Poor to Fair

• Animal studies (cats) in small numbers

• Many are single dose studies

• Rare human drug level studies

• Rare human symptom studies

Page 12: Topical & Transdermal Medications in Palliative Medicine

Topical Diclofenac

• OA, lateral epicondylitis

• 2% topical dicoflenac

• n=74, 14

• Improved pain, stiffness, physical function

• J Rheum 1999, Clin J Sport Med 1998

Page 13: Topical & Transdermal Medications in Palliative Medicine

Topical NSAIDs

• Stay mostly in the dermis

• Can reach synovial fluid

• Efficacy ranges from 18-92%

Page 14: Topical & Transdermal Medications in Palliative Medicine

EMLA Cream/Disc

• Typically used in the pediatric population

• 1G for 60 mins before efficacy

• Localized effect

• 5% emulsion preparation

• Combination of lidocaine and prilocaine

• Strong evidence base

• Patch 60 minutes provides 2 hours of relief

Page 15: Topical & Transdermal Medications in Palliative Medicine

Amethocaine

• 1G amethocaine gel 30 mins

• Better results then EMLA in less time

Page 16: Topical & Transdermal Medications in Palliative Medicine

Topical Ketamine

• No to minimal effect – With neuropathic or capsacin induced pain

• Ionotopheresis assisted delivery

• Open label showed long term effectiveness

• Often combined with amitriptyline

Page 17: Topical & Transdermal Medications in Palliative Medicine

Lidocaine Patch

• 5% Lidocaine

• Topical not transdermal

• Indicated for Post-herpetic Neuralgia

• Tried in – CTS, OA, vaccinations, venipuncture

• Also available as lidocaine gel

Page 18: Topical & Transdermal Medications in Palliative Medicine

Topical Opioids

• Opioid receptors on:– Peripheral nerves– Inflammed skin

• Morphine and metabolites not found systemically

• ? Wound healing mechanism– Up-regulate nitric oxide synthase

Page 19: Topical & Transdermal Medications in Palliative Medicine

Topical Opioids

• Skin infiltration of tumor

• Nonmalignant skin ulcers

• Severe oral mucositis

• Knee arthritis

• Tenesmoid pain.

Pain. 1999 Mar;80(1-2):121-5.

Page 20: Topical & Transdermal Medications in Palliative Medicine

Topical Opioids

• Mostly used for pressure ulcer pain• Relief modest for about 7-8 hours• Gel form

– 10 mg of morphine sulfate injection (10mg/ml)– in 8 gm of Intrasite gel– or gel infused dressing

• Also for burn wounds– MISS->Morphine Infused Silver Sulfadiazene

Page 21: Topical & Transdermal Medications in Palliative Medicine

http://www.supportiveoncology.net/journal/articles/0506289.pdf

Page 22: Topical & Transdermal Medications in Palliative Medicine

Topical Methadone

• Methadone 100mg in 10g Stomadhesive powder

• Varied results in wound application

• Analgesic effects of topical methadone: a report of four cases.

Clin J Pain. 2005 Mar-Apr;21(2):190-2.

Page 23: Topical & Transdermal Medications in Palliative Medicine

Topical antidepressants

• Topical Doxepin combined with capsacin for chronic neuropathic pain

• Doxepin mouthwash improved oral mucosal pain in cancer patients

Page 24: Topical & Transdermal Medications in Palliative Medicine

Transdermal Medications

Page 25: Topical & Transdermal Medications in Palliative Medicine

Testosterone

• Transdermal Patch• Transdermal Cream/Gel

– Testim or Androgel 1% QD

• Injectable, oral, and buccal forms• Indicated for testosterone replacement therapy

– Increased lean body mass, decreased fat mass, increased bone mineral density, increased sexual activity and desire

Page 26: Topical & Transdermal Medications in Palliative Medicine

Transdermal Nicotine

• Approved for nicotine replacement therapy

• Effects of nicotine– Increases glucose, epinephrine– Enhances serotonin and opiate receptors?– Stimulant, but also anxiolytic– Appetite suppressant

• Not indicated in naïve patients

Page 27: Topical & Transdermal Medications in Palliative Medicine

Fentanyl Transdermal Patch

• Well studied

• 92% bioavailable

• Strong mu opioid agonist

• Lipophillic -> High CNS Concentration

• Reservoir and Matrix patches

• Affected by skin thickness and temperature

• Less constipating

Page 28: Topical & Transdermal Medications in Palliative Medicine

Fentanyl Transdermal Patch

Page 29: Topical & Transdermal Medications in Palliative Medicine

Source: Duragesic package insert

Page 30: Topical & Transdermal Medications in Palliative Medicine

Source: Duragesic package insert

Page 31: Topical & Transdermal Medications in Palliative Medicine

Scopolamine Transdermal Patch

• Motion sickness

• Opioid induced nausea

• Smooth muscle spasm

• Parkinson’s

• Drying secretions

• Pyrexia/Sweating

Page 32: Topical & Transdermal Medications in Palliative Medicine

Scopolamine Transdermal Patch

• Belladonna alkaloid (Hyoscine)• Anti-cholinergic• Side effects:

– Drowsiness, dilated pupils, increased HR

• Initial bolus, then 120mcg/d x 3d• Plasma – 4hrs, Peak 24hrs• Post-auricular?• Cost: $8/patch

Page 33: Topical & Transdermal Medications in Palliative Medicine

Transdermal ABHR

• Ativan (lorazepam)– 2 articles

• Benadryl (diphenhydramine)– Case reports

• Haldol (haloperidol)– One study

• Reglan (metoclopramide)– No studies

Page 34: Topical & Transdermal Medications in Palliative Medicine

“Yes, you’re changed; you’ve got new ideas over here,” her friend continued.

“I hope so,” said Isabel; “one should get as many new ideas as possible.”

“Yes; but they shouldn’t interfere with the old ones when the old ones have been the right ones.”

Henry James, Portrait of a Lady

Page 35: Topical & Transdermal Medications in Palliative Medicine

The Future

• More studies

• Med-Tats

• Micro-needles

• Needless jet injectors

• Ionotophoresis

• Phonophoresis

• Liposomal delivery

Page 36: Topical & Transdermal Medications in Palliative Medicine

Review

• Topical vs. Transdermal

• Know the drug

• If it is branded, likely some efficacy

Page 37: Topical & Transdermal Medications in Palliative Medicine

Bibliography

• Carnel SB, Blakesless DB, Oswald SG, Barnes M. Treatment of radiation and chemotherapy-induced stomatitis. Otolaryngol Head Neck Surg. 1990;102:326-30.

• Cerchietti LC, Navigante AH, Bonomi MR et al. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer. 2002;95:2230-2236.

• Flock P. Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain and Symptom Management. 2003;25:547-554.

• Gallagher RE, Arndt DR, Hunt K. Analgesic effects of topical methadone; a report of four cases. Clin J Pain. 2005;21:190-192.

• 5. Kalso E, Tramer MR, Carroll D et al. Pain relief from intra-articular morphine after knee surgery: a qualitative systematic review. Pain. 1997;71:127-34.

Page 38: Topical & Transdermal Medications in Palliative Medicine

Bibliography

• Krajnik M, Zylicz Z, Finlay I et al. Potential uses of topical opioids in palliative care – report of 6 cases. Pain. 1999;80:121-125.

• Picard PR, Tramer MR, McQuay HJ et al. Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomized controlled trials. Pain. 1997;72:309-318.

• Poonawala T, Levay-young BK, Hebbel RP, Gupta K. Opioids heal ischemic wounds in the rat. Wound Repair Regen. 2005;13:165-74.

• Porzio G, Marchetti P. Topical morphine in the treatment of painful ulcers. J Pain and Symptom Management. 2005;30:304-305.

Page 39: Topical & Transdermal Medications in Palliative Medicine

Bibliography

• Twillman RK, Long TD, Cathers TA. Treatment of painful skin ulcers with topical opioids. J Pain and Symptom Management. 1999;17:288-292.

• Vernassiere C, Cornet C, Trechot P et al. Study to determine the efficacy of topical morphine on painful chronic skin ulcers. J Wound Care. 2005;14:289-93.

• Zeppetella G, Paul J, Ribeiro MDC. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain and Symptom Management. 2003;25:555-558.

• Zeppetella G, Joel SP, Ribeiro MD. Stability of morphine sulphate and diamorphine hydrochloride in intrasite gel. Palliat Med. 2005;19:131-6.

• Zeppetella G, Ribeiro MDC. Morphine in Intrasite gel applied topically to painful ulcers. J Pain and Symptom Management. 2005;29:118-119.

Page 40: Topical & Transdermal Medications in Palliative Medicine

Topical CCB

• Diltiazem with lidocaine (PLO) for anal fissures

• Also for anal fissures/hemorrhoids– Preparation H (phenylepherine)– 0.2% glyceryl trinitrate

Page 41: Topical & Transdermal Medications in Palliative Medicine

Topical Capsacin• Topical capsaicin preparations of 0.025 and 0.075%

• Postherpetic neuralgia

• Diabetic neuropathy

• Postmastectomy pain syndrome

• Oral neuropathic pain, Trigeminal neuralgia, and TMJ disorders

• Cluster headache (following intranasal application)

• Osteoarthritis

• Dermatological/cutaneous conditions